Ono Pharmaceutical Co., Ltd. (OPHLY)
5.09
-0.02
(-0.39%)
USD |
OTCM |
Aug 24, 16:00
Ono Pharmaceutical Shareholders Equity (Quarterly) : 5.334B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.334B |
| March 31, 2026 | 5.347B |
| December 31, 2025 | 5.357B |
| September 30, 2025 | 5.460B |
| June 30, 2025 | 5.349B |
| March 31, 2025 | 5.232B |
| December 31, 2024 | 5.192B |
| September 30, 2024 | 5.470B |
| June 30, 2024 | 5.040B |
| March 31, 2024 | 5.239B |
| December 31, 2023 | 5.566B |
| September 30, 2023 | 5.209B |
| June 30, 2023 | 5.275B |
| March 31, 2023 | 5.574B |
| December 31, 2022 | 5.467B |
| September 30, 2022 | 4.867B |
| June 30, 2022 | 4.946B |
| March 31, 2022 | 5.404B |
| December 31, 2021 | 5.737B |
| September 30, 2021 | 6.041B |
| June 30, 2021 | 5.807B |
| March 31, 2021 | 5.739B |
| December 31, 2020 | 6.030B |
| September 30, 2020 | 5.733B |
| June 30, 2020 | 5.407B |
| Date | Value |
|---|---|
| March 31, 2020 | 5.210B |
| December 31, 2019 | 5.222B |
| September 30, 2019 | 5.084B |
| June 30, 2019 | 5.098B |
| March 31, 2019 | 5.035B |
| December 31, 2018 | 4.958B |
| September 30, 2018 | 4.972B |
| June 30, 2018 | 4.889B |
| March 31, 2018 | 4.931B |
| December 31, 2017 | 4.639B |
| September 30, 2017 | 4.460B |
| June 30, 2017 | 4.495B |
| March 31, 2017 | 4.659B |
| December 31, 2016 | 4.324B |
| September 30, 2016 | 4.796B |
| June 30, 2016 | 4.610B |
| March 31, 2016 | 4.194B |
| December 31, 2015 | 3.977B |
| September 30, 2015 | 3.885B |
| June 30, 2015 | 3.867B |
| March 31, 2015 | 3.924B |
| December 31, 2014 | 3.831B |
| September 30, 2014 | 4.121B |
| June 30, 2014 | 4.405B |
| March 31, 2014 | 4.346B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 46.50B |
| Daiichi Sankyo Co., Ltd. | 10.48B |
| Astellas Pharma, Inc. | 11.95B |
| Eisai Co., Ltd. | 5.578B |
| Chugai Pharmaceutical Co., Ltd. | 12.48B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.672B |
| Total Liabilities (Quarterly) | 1.302B |
| Debt to Equity Ratio | 0.1351 |
| Current Ratio | 3.283 |
| Net Debt Paydown Yield | 0.76% |